Pfizer (PFE) and Bristol-Meyers (BMY) win FDA approval for Eliquis

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY

6. AVGO
7. SPCX
8. OSIS
9. BJ
10. BABA

December 28, 2012 4:14 PM EST

Price: $28.05 +0.94%

Overall Analyst Rating:
SELL (= Flat)

Dividend Yield: 6.9%

Pfizer, Inc. (NYSE: PFE) and Bristol-Meyers (NYSE: BMY) win FDA approval for Eliquis, according to Bloomberg headlines.

FDA, General News

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!